107 related articles for article (PubMed ID: 2680910)
1. Adoptive immunity to Mycobacterium bovis strain bacillus Calmette-Guérin by long-term cultured T-cell line in nude mice.
Yamamoto S; Iwai H; Ueda K
Immunology; 1989 Oct; 68(2):253-9. PubMed ID: 2680910
[TBL] [Abstract][Full Text] [Related]
2. Spleen cell transfer induces T cell-dependent granulomas in tuberculous nude mice.
Ueda K; Yamazaki S; Yamamoto S; Someya S
J Reticuloendothel Soc; 1982 Jun; 31(6):469-78. PubMed ID: 6750116
[TBL] [Abstract][Full Text] [Related]
3. Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo.
Pedrazzini T; Hug K; Louis JA
J Immunol; 1987 Sep; 139(6):2032-7. PubMed ID: 3114383
[TBL] [Abstract][Full Text] [Related]
4. H-2 I region restriction phenomenon in T cell-dependent granuloma formation to Mycobacterium bovis BCG.
Ueda K; Yamazaki S; Yamamoto S
J Reticuloendothel Soc; 1983 Dec; 34(6):475-84. PubMed ID: 6418887
[TBL] [Abstract][Full Text] [Related]
5. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
Kramnik I; Radzioch D; Skamene E
Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
7. Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated gamma delta T-cell-depleted mice.
Nabeshima S; Hiromatsu K; Matsuzaki G; Mukasa A; Takada H; Yoshida S; Nomoto K
Immunology; 1995 Feb; 84(2):317-21. PubMed ID: 7751009
[TBL] [Abstract][Full Text] [Related]
8. CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin.
Feng CG; Britton WJ
J Infect Dis; 2000 May; 181(5):1846-9. PubMed ID: 10823799
[TBL] [Abstract][Full Text] [Related]
9. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
Suzuki Y; Remington JS
J Immunol; 1988 Jun; 140(11):3943-6. PubMed ID: 3259601
[TBL] [Abstract][Full Text] [Related]
11. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
12. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
Chou T; Shu S
J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
[TBL] [Abstract][Full Text] [Related]
13. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
14. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
15. Mice that overexpress CC chemokine ligand 2 in their lungs show increased protective immunity to infection with Mycobacterium bovis bacille Calmette-Guérin.
Schreiber O; Steinwede K; Ding N; Srivastava M; Maus R; Länger F; Prokein J; Ehlers S; Welte T; Gunn MD; Maus UA
J Infect Dis; 2008 Oct; 198(7):1044-54. PubMed ID: 18694332
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
Teruya K; Kawakami K; Tohyama M; Saito A
Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
[TBL] [Abstract][Full Text] [Related]
17. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.
Appelberg R; Castro AG; Pedrosa J; Minóprio P
Immunology; 1994 Jul; 82(3):361-4. PubMed ID: 7959868
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
20. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
Bateman WJ; Jenkinson EJ; Owen JJ
Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
